These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21902447)

  • 1. Mental illness and warfarin use in atrial fibrillation.
    Walker GA; Heidenreich PA; Phibbs CS; Go AS; Chiu VY; Schmitt SK; Ananth L; Frayne SM
    Am J Manag Care; 2011 Sep; 17(9):617-24. PubMed ID: 21902447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
    Gurwitz JH; Monette J; Rochon PA; Eckler MA; Avorn J
    Arch Intern Med; 1997 May; 157(9):978-84. PubMed ID: 9140268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in atrial fibrillation: impact of mental illness.
    Schmitt SK; Turakhia MP; Phibbs CS; Moos RH; Berlowitz D; Heidenreich P; Chiu VY; Go AS; Friedman SA; Than CT; Frayne SM
    Am J Manag Care; 2015 Nov; 21(11):e609-17. PubMed ID: 26735294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
    Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
    Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.
    Howard PA; Ellerbeck EF; Engelman KK; Patterson KL
    Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics.
    Choudhry NK; Soumerai SB; Normand SL; Ross-Degnan D; Laupacis A; Anderson GM
    Am J Med; 2006 Jul; 119(7):607-15. PubMed ID: 16828633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National patterns of warfarin use in atrial fibrillation.
    Stafford RS; Singer DE
    Arch Intern Med; 1996 Dec 9-23; 156(22):2537-41. PubMed ID: 8951296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
    Lleva P; Aronow WS; Gutwein AH
    Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of hemorrhage and treatment costs associated with warfarin drug interactions in patients with atrial fibrillation.
    Suh DC; Nelson WW; Choi JC; Choi I
    Clin Ther; 2012 Jul; 34(7):1569-82. PubMed ID: 22717419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation--changes 2000 to 2009.
    Charles J; Pan Y; Miller G
    Aust Fam Physician; 2010 Jul; 39(7):461. PubMed ID: 20628657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
    ROCKET AF Study Investigators
    Am Heart J; 2010 Mar; 159(3):340-347.e1. PubMed ID: 20211293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral anticoagulant use in patients with atrial fibrillation].
    Ertaş F; Duygu H; Acet H; Eren NK; Nazli C; Ergene AO
    Turk Kardiyol Dern Ars; 2009 Apr; 37(3):161-7. PubMed ID: 19553738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
    Lopes RD; Alexander JH; Al-Khatib SM; Ansell J; Diaz R; Easton JD; Gersh BJ; Granger CB; Hanna M; Horowitz J; Hylek EM; McMurray JJ; Verheugt FW; Wallentin L;
    Am Heart J; 2010 Mar; 159(3):331-9. PubMed ID: 20211292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study.
    Menzin J; Boulanger L; Hauch O; Friedman M; Marple CB; Wygant G; Hurley JS; Pezzella S; Kaatz S
    Ann Pharmacother; 2005 Mar; 39(3):446-51. PubMed ID: 15701783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation treatment in real-life practice of patient with nonvalvular atrial fibrillation in Beijing city].
    Zuo HJ; Su JL; Zeng H; Yuan BH; Yao CH
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2328-31. PubMed ID: 18036295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
    Parra D; Beckey NP; Stevens GR
    Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.